Despite success in some cancer patients, a drug that neutralizes GDF-15 was clearly harmful in HF patients. The question is, ...

In postmenopausal women with type 2 diabetes, oral hormone replacement therapy (HRT) may increase the risk of CV events.

The most-read article this month was a look at the new European valve guidelines, with the list fleshed out by news from ESC ...

The data aren’t definitive, but continuing OAC or switching to another drug doesn’t seem to be enough for this high-risk group.

Vocal monitoring has the potential to identify HF patients with worsening congestion early and prevent acute decompensation.

The Integra-D trial shows the device, which provides cardiac contractility modulation and defibrillation, also eases symptoms ...

In 2023, there were 437 million disability-adjusted life-years lost from cardiovascular disease, up from 320 million in 1990.

It’s meant to support the valve guidelines and aid in disentangling the complexities of the tricuspid field, one of the ...

The trial’s findings will dampen enthusiasm for the drug in stroke recovery, though research questions remain, one expert ...

The new SCAI initiative brings optimism for a population that has seen little innovation or changes to treatment paradigms in ...

The paper aims to increase awareness of cardiac long COVID and make management quicker, more accurate, and safer.

Implanting pacemakers in those who meet criteria for prophylactic use appears to be overtreating some patients.